US Rice Bran Market Outlook to 2030

The market includes rice bran sold through its first external commercial transaction as full-fat raw bran, stabilized bran, defatted bran, rice bran oil, waxes, gamma-oryzanol, and other functional extracts. It covers products supplied to livestock feed, pet food, equine nutrition, food and beverages, nutraceuticals, personal care, and industrial users. Rice hulls, brewers rice, finished pet food, consumer supplements, and internally transferred bran that is not commercially sold are excluded to prevent double counting.

The V02 model triangulated three independent methods. Supply-side company modeling produced USD 495 Mn, the operational model produced USD 478 Mn, and the demand-side model produced USD 476 Mn. Applying weights of 50%, 30%, and 20%, respectively, resulted in a rounded base estimate of USD 486 Mn. The operational method used rough-rice production, recoverable bran yield, usable market volume, category-specific pricing, imported specialty products, distribution margins, and exports while excluding internal transfers.

Rice Bran Oil and Extracts is the fastest-growing product segment, with an estimated 9.2% CAGR through 2031. Growth is supported by edible oil, rice bran wax, gamma-oryzanol, antioxidant fractions, clean-label processing aids, and personal-care ingredients. Stabilized Rice Bran also expands above the market average because treatment extends shelf life and allows distribution beyond immediate mill regions. Raw full-fat bran remains important for feed but faces lower pricing, oxidation risk, and more direct competition from other grain co-products.

The near-term supply outlook is restrictive. USDA projected 2026/27 all-rice production at 153.3 million cwt, the lowest level in 39 years, following reduced harvested area. Because bran is produced during domestic milling, imported milled rice cannot fully replace lost domestic bran availability. The model therefore forecasts lower bran-equivalent volume in 2026 but continued market-value growth from higher realized prices and a greater specialty-product mix. Volume growth resumes from 2027 under normalized acreage and yield assumptions.

Livestock Feed is the largest application at 37% of 2025 value, followed by Pet Food at 24%. Feed demand is supported by rice bran's fat, fiber, protein, and digestible-energy profile. Pet food and equine nutrition generate higher value per ton because buyers require stabilization, palatability, oxidation control, lot traceability, and tighter specifications. Food, nutraceutical, and personal-care applications are smaller but grow faster and account for a rising share of incremental market value through 2031.

Suppliers must comply with preventive controls, current good manufacturing practices, labeling, supplier verification, traceability, and contaminant-testing expectations. Inorganic arsenic is commercially significant because bran can contain more outer-grain contaminants than polished rice. FDA's 100 ppb action level for infant rice cereal does not apply universally to every bran product, but it influences customer specifications and sourcing practices. Rice bran wax has an explicit permitted-use pathway under 21 CFR 172.890, while extracts require appropriate regulatory and safety substantiation.

Winning suppliers require secure bran access, rapid stabilization, consistent recovery yield, oxidation control, contaminant testing, segregated storage, traceability, and reliable bulk logistics. Food and nutraceutical players also need validated extraction, standardized actives, application laboratories, certificates, regulatory documentation, and distributor training. Commercial success depends on matching each ton of bran with the application capable of generating the strongest risk-adjusted contribution margin while retaining outlets for defatted meal and other residual fractions.